Webinar

Why is Tenecteplase Still a Drug of Choice & Cost Effective?

15th January, 2013
06:00 PM

Overview

In this webinar, Dr I Sathyamurthy is talking about Why is tenecteplase still a drug of choice & cost effective?

  Speakers

Dr. Immaneni  Sathyamurthy

Dr. Immaneni Sathyamurthy

Director of the Department of Cardiology at Apollo Hospitals in Chennai


Dr. KK Aggarwal

Dr. KK Aggarwal

President Heart Care Foundation of India and Group Editor in Chief MEDtalks


Powered By

sponser
Why is Tenecteplase Still a Drug of Choice & Cost Effective? | Live Webinar | Medtalks
Logo

Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks

Download Our App

Connect With Us